<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE307nnn/GSE307781/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Other</omics_type><species>Homo sapiens</species><gds_type>Other</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307781</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>T follicular helper 1 cells in blood potentially mirror salivary gland-infiltrating T cells in Sjögren’s disease</name><description>Understanding the intricate relationship between peripheral blood immune profiles and the inflammatory environment within affected tissues is pivotal for uncovering mechanisms driving autoimmune diseases. This study aimed to characterize CD4+ T cell subsets in peripheral blood that mirror the inflammatory milieu of labial salivary glands (LSG) in primary Sjögren’s disease (pSjD). Using multicolor flow cytometry and T cell receptor (TCR) sequencing, we identified CXCR3+CXCR5+ T follicular helper 1 (Tfh1) cells as significantly elevated in the circulation of pSjD patients and even more prominently increased in the LSG, with blood PD-1+ICOS+ Tfh1 cells positively correlating with titers of antinuclear, anti-SS-A, and anti-SS-B antibodies. In contrast, CXCR3+CXCR5− Th1 cells were enriched in LSG but reduced in circulation. TCR analysis demonstrated that circulating Tfh1 cells shared extensive clonal similarity with LSG T cells. In the LSG, cytokines such as IL-6, IL-12, IL-21, and TGF-β were upregulated, with TGF-β and TCR recognition promoting Tfh1 differentiation. This microenvironment led to increased production of IL-2, TNF-α, and IL-21, promoting the expansion of CD19+CD38+ B cells. These findings underscore circulating Tfh1 cells as reflections of glandular inflammation and highlight TGF-β as a key driver of Tfh1 differentiation, presenting a potential therapeutic target.</description><dates><publication>2026/07/02</publication></dates><accession>GSE307781</accession><cross_references><GSM>GSM9231271</GSM><GSM>GSM9231260</GSM><GSM>GSM9231272</GSM><GSM>GSM9231261</GSM><GSM>GSM9231262</GSM><GSM>GSM9231263</GSM><GSM>GSM9231270</GSM><GSM>GSM9231268</GSM><GSM>GSM9231269</GSM><GSM>GSM9231259</GSM><GSM>GSM9231264</GSM><GSM>GSM9231265</GSM><GSM>GSM9231266</GSM><GSM>GSM9231267</GSM><GPL>24676</GPL><GSE>307781</GSE><taxon>Homo sapiens</taxon><PMID>[40604050]</PMID></cross_references></HashMap>